Letrozole as primary medical therapy for locally advanced and large operable breast cancer

J M Dixon; C D Love; C O Bellamy; D A Cameron; R C Leonard; H Smith; W R Miller

doi:10.1023/A:1010669403283

Letrozole as primary medical therapy for locally advanced and large operable breast cancer

J M Dixon, C D Love, C O Bellamy, D A Cameron, R C Leonard, H Smith, W R Miller

Research output: Contribution to journal › Article › peer-review

Abstract

To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast cancer.

Original language	English
Pages (from-to)	191-9
Number of pages	9
Journal	Breast cancer research and treatment
Volume	66
Issue number	3
DOIs	https://doi.org/10.1023/A:1010669403283
Publication status	Published - Apr 2001

Keywords / Materials (for Non-textual outputs)

Aged
Aged, 80 and over
Antineoplastic Agents
Breast Neoplasms
Dose-Response Relationship, Drug
Female
Humans
Mastectomy, Segmental
Middle Aged
Neoadjuvant Therapy
Nitriles
Postmenopause
Receptors, Estrogen
Treatment Outcome
Triazoles

Access to Document

10.1023/A:1010669403283

Cite this

@article{9bba3909584f4913845b36b5c1e35e55,

title = "Letrozole as primary medical therapy for locally advanced and large operable breast cancer",

abstract = "To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast cancer.",

keywords = "Aged, Aged, 80 and over, Antineoplastic Agents, Breast Neoplasms, Dose-Response Relationship, Drug, Female, Humans, Mastectomy, Segmental, Middle Aged, Neoadjuvant Therapy, Nitriles, Postmenopause, Receptors, Estrogen, Treatment Outcome, Triazoles",

author = "Dixon, {J M} and Love, {C D} and Bellamy, {C O} and Cameron, {D A} and Leonard, {R C} and H Smith and Miller, {W R}",

year = "2001",

month = apr,

doi = "10.1023/A:1010669403283",

language = "English",

volume = "66",

pages = "191--9",

journal = "Breast cancer research and treatment",

issn = "0167-6806",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Letrozole as primary medical therapy for locally advanced and large operable breast cancer

AU - Dixon, J M

AU - Love, C D

AU - Bellamy, C O

AU - Cameron, D A

AU - Leonard, R C

AU - Smith, H

AU - Miller, W R

PY - 2001/4

Y1 - 2001/4

N2 - To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast cancer.

AB - To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast cancer.

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Agents

KW - Breast Neoplasms

KW - Dose-Response Relationship, Drug

KW - Female

KW - Humans

KW - Mastectomy, Segmental

KW - Middle Aged

KW - Neoadjuvant Therapy

KW - Nitriles

KW - Postmenopause

KW - Receptors, Estrogen

KW - Treatment Outcome

KW - Triazoles

U2 - 10.1023/A:1010669403283

DO - 10.1023/A:1010669403283

M3 - Article

C2 - 11510690

SN - 0167-6806

VL - 66

SP - 191

EP - 199

JO - Breast cancer research and treatment

JF - Breast cancer research and treatment

IS - 3

ER -

Letrozole as primary medical therapy for locally advanced and large operable breast cancer

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Cite this